miR-152/TNS1 axis inhibits non-small cell lung cancer progression through Akt/mTOR/RhoA pathway
Author(s) -
Jinjin Duan,
Li Wang,
Liqun Shang,
ShuMei Yang,
Hua Wu,
Yongcheng Huang,
Yi Miao
Publication year - 2020
Publication title -
bioscience reports
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.938
H-Index - 77
eISSN - 1573-4935
pISSN - 0144-8463
DOI - 10.1042/bsr20201539
Subject(s) - rhoa , pi3k/akt/mtor pathway , protein kinase b , cancer research , cell growth , western blot , metastasis , flow cytometry , lung cancer , mtt assay , cell , chemistry , medicine , biology , signal transduction , oncology , cancer , microbiology and biotechnology , biochemistry , gene
The purpose of the present study was to explore the function and mechanism of tensin 1 (TNS1) in non-small cell lung cancer (NSCLC) progression.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom